Table 2.
Utilization of MCPAP program addiction medicine consultation calls, 2020–2023 (N = 130 practices).
| Year (s) | Non-PPOC, N = 80 (Practices) | PPOC, N = 50 (Practices) | ||||||
|---|---|---|---|---|---|---|---|---|
| Consultation Callsa, total |
Practices Using Consultation, n (%)b |
McNemar test P-valuec |
Cochran's Q test P-valued |
Consultation Callsa, total |
Practices Using Consultation, n (%)b |
McNemar test P-valuec |
Cochran's Q test P-valued |
|
| 2020 | 15 | 13 (16.2%) | NA | <0.001 | 34 | 18 (36.0%) | NA | 0.14 |
| 2021 | 60 | 35 (43.8%) | <0.001 | 44 | 23 (46.0%) | 0.38 | ||
| 2022 | 117 | 60 (75.0%) | <0.001 | 74 | 30 (60.0%) | 0.25 | ||
| 2023 | 39 | 25 (31.2%) | <0.001 | 55 | 24 (48.0%) | 0.29 | ||
MCPAP, Massachusetts Child Psychiatry Access Program; PPOC,The Pediatric Physicians’ Organization at Boston Children's Hospital.
The total annual number of Addiction Medicine consultation calls from the practices.
The percentage of practices within the group that utilized Addiction Medicine consultation calls.
The McNemar test was used to compare the annual changes in the proportion of Addiction Medicine call utilization within each group for consecutive years: 2020–2021, 2021–2022, and 2022–2023.
Cochran's Q test was used to evaluate the consistency in the proportion of Addiction Medicine call utilization within each group over the period 2020–2023.